Welcome to the RYLAZE® (asparaginase erwinia chrysanthemi (recombinant)-rywn) page! This space was created for people impacted by acute lymphoblastic leukemia (ALL) and lymphoblastic lymphoma (LBL). Here, people living with ALL and LBL as well as their loved ones can learn more about RYLAZE and connect with others who may have similar interests and experiences. RYLAZE is a prescription medicine, given by intramuscular injection, that is part of a chemotherapy regimen used to treat adults and children 1 month or older who have acute lymphoblastic leukemia (ALL), a type of blood cancer that affects the white blood cells that help fight infection, and lymphoblastic lymphoma (LBL), a type of Non-Hodgkin lymphoma that also affects white blood cells. Coli asparaginase. Ask your healthcare provider if RYLAZE is right for you. The JazzCares® program at Jazz Pharmaceuticals helps patients get access to medications and support services, which includes financial support for those who can't afford their medication. Patients may call JazzCares for help Monday-Friday, 8 AM-8 PM ET, at 1-833-533-JAZZ (5299). From time to time, this page may share links to third-party sites that you may find useful. Jazz Pharmaceuticals does not endorse and is not responsible for the content of these third-party sites. To learn more about RYLAZE, visit www.RYLAZE.com. You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch, or call 1-800-FDA-1088. For information about adverse events or product complaints related to Jazz Pharmaceuticals’ products, visit www.jazzpharma.com/medicines/drug-safety. This page is for US residents 18 years of age or older. US-ASN-2200042 Rev1024
